logo-loader
viewSpirent Communications

Spirent Communications shares jump as it expects full year profit to beat market forecasts

Spirent Communications said full year revenue gained 6%, driven by growth in the networks and security division

ethernet
Spirent saw strong demand for 400G high-speed ethernet testing services

Spirent Communications PLC (LON:SPT) expects full year profit to exceed market forecasts after cutting costs and growing revenue.

The IT network products specialist said its order intake for the year totalled US$470mln, up 6% on the previous year, and revenue gained 6% to US$477mln.

Growth was led by its networks and security division, boosted by demand for 400G high-speed ethernet testing services.

Revenue was also supported by a US$10mln contribution from one-off business with a US defence contractor, which the company does not expect to be repeated in 2019.

The Lifecycle Service Assurance business only saw modest revenue growth due to a major reorganisation in the key customer base.

Spirent said the Connected Devices arm delivered “strong profit growth” in the year, driven by effective cost management.

READ: Spirent chief executive to retire after 36 years at networking specialist

Following efforts to mitigate higher inflation with cost cuts, the company now expects adjusted operating profit of US$75mln to US$77mln, up 30% on the prior year and above analysts’ estimates.

The group had cash of just over US$120mln at the end of the period after dividend payments.

Shares rose 7.3% to 134.35p in morning trading. 

Quick facts: Spirent Communications

Price: 227 GBX

LSE:SPT
Market: LSE
Market Cap: £1.39 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 8 hours ago

RNS

Block listing Interim Review

5 days, 4 hours ago

Trading Statement

5 days, 13 hours ago

Total Voting Rights

2 weeks, 2 days ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Total Voting Rights

on 2/12/19

Holding(s) in Company

on 28/11/19

Director Declaration

on 13/11/19

2 min read